Markets · 1 sources covering this

Moderna stock crashes 25%, loses about $24 billion after cancer vaccine data leak

Moderna’s stock price dropped over 25% after trial results for its personalized melanoma vaccine with Merck were disclosed. The decline erased approximately $24 billion from Moderna’s market value, ending a significant rally this year. Analysts noted that this reaction was expected as investors often sell after news becomes public. Despite the drop, the trial results showed promising reductions in cancer recurrence when paired with Merck's Keytruda.

Share:WhatsApp X Reddit Facebook LinkedIn

Coverage spectrum

0 L · 0 C · 1 R

How 1 sources are covering this

Economic TimesLean R·2h ago
Moderna stock crashes 25%, loses about $24 billion after cancer vaccine data leak
Moderna’s stock price dropped over 25% after trial results for its personalized melanoma vaccine with Merck were disclosed. The decline erased approximately $24 billion from Moderna’s market value, ending a significant rally this year. Analysts noted that this reaction was expected as investors often sell after news becomes public. Despite the drop, the trial results showed promising reductions in cancer recurrence when paired with Merck's Keytruda.
Read at Economic Times →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/67096a4d88496c815a72eda5c9352a6ed5fd0948"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Moderna stock crashes 25%, loses about $24 billion after cancer vaccine data leak"></iframe>

Moderna stock crashes 25%, loses about $24 billion after cancer vaccine data leak

How 1 sources are covering this